An Irish company could be set to revolutionise the rollout of Covid-19 vaccines all over the planet, streamlining a process the world is waiting for.
Pharmapod, an Irish company headed up by Roscommon entrepreneur Leonora O’Brien, is in the final stages of developing an online solution for the administration of a coronavirus vaccine.
The software company – founded back in 2013 – has international backing for a cloud-based system that will streamline the vaccination process for both patients and healthcare staff.
The International Pharmaceutical Federation is collaborating with Pharmapod as it moves into the final stages of prepping the online application.
The system, which Pharmapod hopes to kick off in tandem with the rollout of the vaccine, will allow patients to book their vaccination appointment and provide real-time information to healthcare professionals and their organisations.
And it could also help with teething problems when it comes to the distribution of vaccinations – helping Governments in the coming weeks and months as they struggle to dole out a Covid-19 salve to the masses.
“Essentially, the system will streamline the end-to-end process for patients and those administrating the vaccine,” said Ms O’Brien ahead of its release.
“This will allow the public to easily book their vaccine via any device, schedule multiple doses, complete their eligibility criteria and provide details of any side-effects that have occurred.
“The data will flow securely from patient to administrator to national stakeholders and governmental organisations.
“Public health authorities will be able to receive real time, anonymous information about how the vaccine rollout is working.
“By simplifying the entire process, the solution promotes vaccine uptake, minimises the time required to administer each vaccine and provides critical data on side-effects so that corrective actions may be put in place as required.
“The vaccination system will also be able to spot potential problems in the rollout such as shortages of vaccines, uptake resistance, people not showing up for vaccinations, regional uptake comparisons, etc.”
